Neuroinflammation in the context of cancer and cancer-treatment is frequently characterized by changes in expression of proinflammatory cytokines such as IL- 1β, IFN-γ IL-6, and TNF-α [47, 51]. This evidence concerns the gene IFNG and cancer.